Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype.
A trial of autologous hematopoietic stem cell transplantation to treat multiple sclerosis has yielded promising results, generating considerable interest within both the clinical literature and the mainstream press.the findings should, however, be interpreted with some caution, and larger, randomized trials will be required to establish the true efficacy of the approach.
Stangel
Martin
M
Department of Neurology, Hannover Medical School, Carl-Neuberg-Strasse 1, Hannover, Germany. stangel.martin@mh-hannover.de
D002986:Clinical Trials as Topic; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D009103:Multiple Sclerosis / Q000601:surgery*; D014182:Transplantation, Autologous / Q000379:methods; D016896:Treatment Outcome